These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30093345)

  • 1. Novel benzodiazepines derivatives as analgesic modulating for Transient receptor potential vanilloid 1.
    Liu Y; Liao C; Zhou J; Liu C; Li Q; Jiang Y; Qian H
    Bioorg Med Chem; 2018 Aug; 26(15):4567-4573. PubMed ID: 30093345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-tert-Butyl-6-(4-chloro-phenyl)-2-thioxo-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one, a classic polymodal inhibitor of transient receptor potential vanilloid type 1 with a reduced liability for hyperthermia, is analgesic and ameliorates visceral hypersensitivity.
    Nash MS; McIntyre P; Groarke A; Lilley E; Culshaw A; Hallett A; Panesar M; Fox A; Bevan S
    J Pharmacol Exp Ther; 2012 Aug; 342(2):389-98. PubMed ID: 22566669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel piperazine urea derivatives as highly potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Hu J; Gao M; Zhang Y; Wang Y; Qiao Z; Zhang W; Wang Q; Yan L; Qian H
    Bioorg Chem; 2021 Oct; 115():105229. PubMed ID: 34364049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel phenylpiperazine derivatives as potent transient receptor potential vanilloid 1 antagonists.
    Jing L; Liu C
    Chem Biol Drug Des; 2024 Jul; 104(1):e14584. PubMed ID: 38997239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
    García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
    J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Aminophenyl acetamides and propanamides as potent transient receptor potential vanilloid 1 (TRPV1) ligands.
    Kim C; Ann J; Lee S; Kim E; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem; 2018 Aug; 26(15):4509-4517. PubMed ID: 30078610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8-carboxamide (JTS-653), a novel transient receptor potential vanilloid 1 antagonist.
    Kitagawa Y; Miyai A; Usui K; Hamada Y; Deai K; Wada M; Koga Y; Sakata M; Hayashi M; Tominaga M; Matsushita M
    J Pharmacol Exp Ther; 2012 Aug; 342(2):520-8. PubMed ID: 22588258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats.
    Lehto SG; Tamir R; Deng H; Klionsky L; Kuang R; Le A; Lee D; Louis JC; Magal E; Manning BH; Rubino J; Surapaneni S; Tamayo N; Wang T; Wang J; Wang J; Wang W; Youngblood B; Zhang M; Zhu D; Norman MH; Gavva NR
    J Pharmacol Exp Ther; 2008 Jul; 326(1):218-29. PubMed ID: 18420600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylquinoline transient receptor potential vanilloid 1 antagonists for the treatment of pain: Discovery of 1-(2-phenylquinoline-4-carbonyl)-N-(4-(trifluoromethyl)phenyl)pyrrolidine-3-carboxamide.
    Liao C; Liu Y; Liu C; Zhou J; Li H; Wang N; Li J; Liu T; Ghaleb H; Huang W; Qian H
    Bioorg Med Chem; 2018 Feb; 26(4):845-854. PubMed ID: 29317149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrahydropyridine-4-carboxamides as novel, potent transient receptor potential vanilloid 1 (TRPV1) antagonists.
    Brown BS; Keddy R; Zheng GZ; Schmidt RG; Koenig JR; McDonald HA; Bianchi BR; Honore P; Jarvis MF; Surowy CS; Polakowski JS; Marsh KC; Faltynek CR; Lee CH
    Bioorg Med Chem; 2008 Sep; 16(18):8516-25. PubMed ID: 18722778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
    Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
    J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides.
    Ha TH; Ryu H; Kim SE; Kim HS; Ann J; Tran PT; Hoang VH; Son K; Cui M; Choi S; Blumberg PM; Frank R; Bahrenberg G; Schiene K; Christoph T; Frormann S; Lee J
    Bioorg Med Chem; 2013 Nov; 21(21):6657-64. PubMed ID: 24035514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.
    Ann J; Jung A; Kim MY; Kim HM; Ryu H; Kim S; Kang DW; Hong S; Cui M; Choi S; Blumberg PM; Frank-Foltyn R; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem; 2015 Nov; 23(21):6844-54. PubMed ID: 26474664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of (R)-1-(7-chloro-2,2-bis(fluoromethyl)chroman-4-yl)-3-(3-methylisoquinolin-5-yl)urea (A-1165442): a temperature-neutral transient receptor potential vanilloid-1 (TRPV1) antagonist with analgesic efficacy.
    Voight EA; Gomtsyan AR; Daanen JF; Perner RJ; Schmidt RG; Bayburt EK; DiDomenico S; McDonald HA; Puttfarcken PS; Chen J; Neelands TR; Bianchi BR; Han P; Reilly RM; Franklin PH; Segreti JA; Nelson RA; Su Z; King AJ; Polakowski JS; Baker SJ; Gauvin DM; Lewis LR; Mikusa JP; Joshi SK; Faltynek CR; Kym PR; Kort ME
    J Med Chem; 2014 Sep; 57(17):7412-24. PubMed ID: 25100568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.
    Kim MS; Ryu H; Kang DW; Cho SH; Seo S; Park YS; Kim MY; Kwak EJ; Kim YS; Bhondwe RS; Kim HS; Park SG; Son K; Choi S; DeAndrea-Lazarus IA; Pearce LV; Blumberg PM; Frank R; Bahrenberg G; Stockhausen H; Kögel BY; Schiene K; Christoph T; Lee J
    J Med Chem; 2012 Oct; 55(19):8392-408. PubMed ID: 22957803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Analogues of BCTC Incorporating a Pyrrolidinyl Linker and Biological Evaluation as Transient Receptor Potential Vanilloid 1 Antagonists.
    Yan L; Wang J; Pan M; Qiu Q; Huang W; Qian H
    Chem Biol Drug Des; 2016 Feb; 87(2):306-11. PubMed ID: 26360809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists.
    Li J; Nie C; Qiao Y; Hu J; Li Q; Wang Q; Pu X; Yan L; Qian H
    Eur J Med Chem; 2019 Sep; 178():433-445. PubMed ID: 31202991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship studies and discovery of a potent transient receptor potential vanilloid (TRPV1) antagonist 4-[3-chloro-5-[(1S)-1,2-dihydroxyethyl]-2-pyridyl]-N-[5-(trifluoromethyl)-2-pyridyl]-3,6-dihydro-2H-pyridine-1-carboxamide (V116517) as a clinical candidate for pain management.
    Tafesse L; Kanemasa T; Kurose N; Yu J; Asaki T; Wu G; Iwamoto Y; Yamaguchi Y; Ni C; Engel J; Tsuno N; Patel A; Zhou X; Shintani T; Brown K; Hasegawa T; Shet M; Iso Y; Kato A; Kyle DJ
    J Med Chem; 2014 Aug; 57(15):6781-94. PubMed ID: 25057800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 1-(1H-indazol-4-yl)-3-((1-phenyl-1H-pyrazol-5-yl)methyl) ureas as potent and thermoneutral TRPV1 antagonists.
    Kang JM; Kwon SO; Ann J; Blumberg PM; Ha H; Yoo YD; Frank-Foltyn R; Lesch B; Bahrenberg G; Stockhausen H; Christoph T; Lee J
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127548. PubMed ID: 32931910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of (S)-N-(3-isopropylphenyl)-2-(5-phenylthiazol-2-yl)pyrrolidine-1-carboxamide as potent and brain-penetrant TRPV1 antagonist.
    Qiao Y; Zhang Y; Qiao Z; He W; Chen Y; Song D; Wang G; Guo N; Shao L; Tian Z; Wang Q; Yan L; Qian H
    Eur J Med Chem; 2022 Apr; 233():114191. PubMed ID: 35263708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.